![Alan Tyndall](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alan Tyndall active positions
Companies | Position | Start | End |
---|---|---|---|
University of Basel | Corporate Officer/Principal | 1990-12-31 | - |
World Scleroderma Foundation | Corporate Secretary | - | - |
Iterata AG | Director/Board Member | - | - |
Founder | - | - |
Career history of Alan Tyndall
Former positions of Alan Tyndall
Companies | Position | Start | End |
---|---|---|---|
MAGENTA THERAPEUTICS | Founder | 2015-06-16 | - |
Training of Alan Tyndall
The University of Sydney | Undergraduate Degree |
Statistics
International
Switzerland | 4 |
United States | 2 |
Japan | 2 |
Operational
Founder | 2 |
Corporate Officer/Principal | 1 |
Corporate Secretary | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Magenta Therapeutics, Inc.
![]() Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
World Scleroderma Foundation | |
Iterata AG |
- Stock Market
- Insiders
- Alan Tyndall
- Experience